$MBVX MABVAX THERAPEUTICS HOLDINGS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in MABVAX THERAPEUTICS HOLDINGS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
MABVAX THERAPEUTICS HOLDINGS, INC. Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Antonopoulos Jim J. | 21,258 | 63,136 | Sep 15 2014 | ||||
Barry Richard | 10% Owner | 243,800 | 724,086 | Dec 19 2012 | |||
Barry Richard J. | 10% Owner | 11,847,125 | 35,185,961 | Dec 15 2010 | |||
BLACK BEAR OFFSHORE MASTER FUND LP | 10% Owner | 10,436,232 | 30,995,609 | May 07 2007 | |||
BLACK BEAR OFFSHORE MASTER FUND LP | 10% Owner | 8,062,678 | 23,946,154 | Jun 25 2008 | |||
BLACK BEAR OFFSHORE MASTER FUND LP | 10% Owner | 8,375,542 | 24,875,360 | Sep 23 2009 | |||
BLACK BEAR OFFSHORE MASTER FUND LP | 10% Owner | 9,490,487 | 28,186,746 | Feb 12 2009 | |||
BLACK BEAR OFFSHORE MASTER FUND LP | 10% Owner | 9,364,802 | 27,813,462 | Sep 18 2009 | |||
BUTITTA CYNTHIA M | COO and CFO | 12,147 | 36,077 | Sep 16 2004 | |||
BUTITTA CYNTHIA M | COO and CFO | 31,074 | 92,290 | Mar 16 2005 | |||
BUTITTA CYNTHIA M | COO and CFO | 36,573 | 108,622 | Nov 18 2009 | |||
CANTRALL EDWARD W | Director | 10,000 | 29,700 | Aug 20 2004 | |||
CANTRALL EDWARD W | Director | 0 | 0 | May 31 2005 | |||
CANTRALL EDWARD W | Director | 50,000 | 148,500 | Aug 23 2010 | |||
CANTRALL EDWARD W | Director | 0 | 0 | Apr 03 2012 | |||
CANTRALL EDWARD W | Director | 0 | 0 | May 17 2013 | |||
Cohen Kenneth M | Director | 96,351 | 286,162 | Feb 23 2018 | |||
Cohen Kenneth M | Director | 17,616 | 52,320 | Dec 18 2014 | |||
EASTBOURNE CAPITAL MANAGEMENT LLC/CA | 10% Owner | 11,850,000 | 35,194,500 | Sep 30 2009 | |||
EASTBOURNE CAPITAL MANAGEMENT LLC/CA | 10% Owner | 1,532,709 | 4,552,146 | May 12 2010 | |||
EISENBERG JEFFREY F | 82,556 | 245,191 | Feb 23 2018 | ||||
FRICK ROBERT W | Director | 5,000 | 14,850 | Dec 19 2003 | |||
FRICK ROBERT W | Director | 10,000 | 29,700 | May 31 2005 | |||
FRICK ROBERT W | Director | 0 | 0 | May 22 2008 | |||
GOLDRING STEVEN R | Director | 0 | 0 | May 14 2004 | |||
GOLDRING STEVEN R | Director | 0 | 0 | May 22 2009 | |||
GOLDRING STEVEN R | Director | 0 | 0 | May 17 2013 | |||
GOMEZ REINALDO F | Senior Vice President, | 111,542 | 331,280 | Feb 27 2004 | |||
GOMEZ REINALDO F | Senior Vice President, | 0 | 0 | Dec 14 2004 | |||
GRAY MARY ANN | Director | 5,000 | 14,850 | May 31 2005 | |||
GRAY MARY ANN | Director | 0 | 0 | May 22 2008 | |||
HANSEN JOHN DAVID | PRESIDENT AND CEO | 536,730 | 1,594,088 | Feb 23 2018 | |||
HANSON GREGORY P | CHIEF FINANCIAL OFFICER, SECR | 320,013 | 950,439 | Feb 23 2018 | |||
HANSON GREGORY P | Chief Financial Officer | 3,000 | 8,910 | Dec 17 2014 | |||
HOFFMAN ROBERT | Director | 4,438 | 13,181 | May 23 2017 | |||
HOFFMAN ROBERT | Director | 21,116 | 62,715 | Dec 17 2014 | |||
Kaplan William Phillip | VP, General Counsel and | 0 | 0 | Nov 18 2009 | |||
Kaplan William Phillip | VP, General Counsel and | 0 | 0 | May 25 2011 | |||
Livingston Philip O. | CHIEF SCIENCE OFFICER | 293,581 | 871,936 | Feb 23 2018 | |||
MAFFUID PAUL W | EXECUTIVE VICE PRESIDENT | 283,703 | 842,598 | Feb 23 2018 | |||
MAIER PAUL V | Director | 86,313 | 256,350 | Feb 23 2018 | |||
NEWMAN RICHARD B | Director | 8,472 | 25,162 | Aug 16 2004 | |||
NEWMAN RICHARD B | Director | 0 | 0 | May 31 2005 | |||
NEWMAN RICHARD B | Director | 0 | 0 | May 22 2009 | |||
NEWMAN RICHARD B | Director | 0 | 0 | Apr 03 2012 | |||
NEWMAN RICHARD B | Director | 0 | 0 | May 17 2013 | |||
Ravetch Jeffrey V. | Director | 3,086 | 9,165 | Jun 14 2017 | |||
Resnick Paul F | VICE PRESIDENT, CBO | 18,333 | 54,449 | Feb 23 2018 | |||
RYSER STEFAN | Director | 0 | 0 | May 14 2004 | |||
RYSER STEFAN | SVP, Corporate Strategy | 0 | 0 | May 18 2009 | |||
Scholz Wolfgang W. | VP OF ANTIBODY DISCOVERY | 113,288 | 336,465 | Apr 05 2016 | |||
Schow Steven R | Vice President, Research | 0 | 0 | May 25 2011 | |||
Steuer Marc | SVP - Business Development | 0 | 0 | Jan 10 2005 | |||
Steuer Marc | SVP - Business Development | 0 | 0 | Nov 18 2009 | |||
Steuer Marc | SVP - Business Development | 0 | 0 | May 26 2011 | |||
Varvaro Thomas C | 23,063 | 68,497 | Apr 03 2018 | ||||
von Morze Herwig | Director | 0 | 0 | May 31 2005 | |||
von Morze Herwig | Director | 22,000 | 65,340 | May 22 2009 | |||
von Morze Herwig | Director | 0 | 0 | Apr 03 2012 | |||
Wee Wendy | VP, Finance & Controller | 0 | 0 | May 25 2011 | |||
WICK MICHAEL M | Director | 33,551 | 99,646 | Apr 07 2015 | |||
WICK MICHAEL M | President, CEO and Chairman | 0 | 0 | Jan 10 2005 | |||
WICK MICHAEL M | President, CEO and Chairman | 162,391 | 482,301 | Jun 17 2010 | |||
WICK MICHAEL M | President, CEO and Chairman | 0 | 0 | May 25 2011 |